Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

NativeMed vs OrderlyMeds

NativeMed
Graded #191

Lower grade

vs+1.4000000000000057
OrderlyMeds
Graded #161

Higher grade

The verdict

OrderlyMeds takes it — 67.9/100 to 66.5/100, but only just.

OrderlyMeds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth provider offering one of the lowest 3-month starter prices for compounded GLP-1 medications. NativeMed is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
74
74
Dose & formulationEven
64
64
Clinical oversightOrderlyMeds +8
74
82
Labs & monitoringEven
53
53
FulfillmentNativeMed +2
67
65
Contract termsEven
55
55
NativeMed · left barOrderlyMeds · right bar

The numbers

MetricNativeMedOrderlyMeds
WeighScore66.5/10067.9/100
GradeCC
Scorecard rank#191#161
Semaglutide$149/mo (promotional rate, compounded)$149/mo (starting dose, compounded)
Tirzepatide$183/mo (promotional rate, compounded)$299/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
NativeMed

Graded #191 · C

Strengths

  • LegitScript Certified (verifiable in the footer)
  • Promotional pricing shown publicly: $149/mo semaglutide, $183/mo tirzepatide
  • Online questionnaire intake, with a live visit added when state law requires it

Where it loses points

  • Pharmacy partners aren't named — described only as 'USA-based' or 'accredited' pharmacies
  • States served aren't listed publicly
  • Prices are promotional — confirm whether they hold past month one or rise to the $299/$399 regular rate
OrderlyMeds

Graded #161 · C

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard